Open access

Showing results 21 - 30 of 100

Sorted by most recent

TitleAuthorDate

Implementation of an ISO 15189 accredited next generation sequencing service for cell-free total nucleic acid (cfTNA) analysis to facilitate driver mutation reporting in blood: the experience of a clinical diagnostic laboratory

Reiltin Werner, Ruth Crosbie, Mairead Dorney, Amy Connolly, Dearbhaile Collins, Collette K Hand, Louise Burke

24 June 2024

Morphology combined with HER2 D-DISH ploidy analysis to diagnose partial hydatidiform mole: an evaluation audit using molecular genotyping

Caroline M Joyce, Geoffrey J Maher, Susan Dineen, Nirosha Suraweera, Tommie V McCarthy, John Coulter, Keelin O'Donoghue, Michael J Seckl, Brendan Fitzgerald

30 March 2024

Appraisal of hydatidiform mole incidence and registration rates in Ireland following the establishment of a National Gestational Trophoblastic Disease Registry

Caroline M Joyce, Craig Wakefield, Daphne Chen-Maxwell, Susan Dineen, Caitriona Kenneally, Paul Downey, Catherine Duffy, Keelin O'Donoghue, John Coulter, Brendan Fitzgerald

30 March 2024

Novel scoring system provides high separation of diploidy and triploidy to aid partial hydatidiform mole diagnosis: an adaption of HER2 D-DISH for ploidy analysis

Caroline M Joyce, Susan Dineen, Julie Deane, Niamh Conlon, Paula M O'Shea, Paul Corcoran, John Coulter, Keelin O'Donoghue, Brendan Fitzgerald

30 March 2024

Primary desmoplastic small round cell tumour of the prostate

Jingyu Qian, Yanjin Yang, Xin Xie, Yifan Kang, Jinjing Zhong, Xueqin Chen, Ni Chen, Qiao Zhou, Ling Nie

29 July 2024

Reappraisal and refined diagnosis of ultrasonography and histological findings for hydatidiform moles: a multicentre retrospective study of 821 patients

Yating Zhao, Limeng Cai, Bo Huang, Xiangang Yin, Dan Pan, Jie Dong, Lei Zheng, Hao Chen, Jun Lin, Huafeng Shou, Zhigang Zhao, Lanying Jin, Xiaoxu Zhu, Luya Cai, Xiaofei ZhangSee the full list of authors

24 July 2024

Does an electronic pathology ordering system change the volume and pattern of routine testing in hospital? An interrupted time series analysis

Madeleine de Carle, Brooke Macnab, Jenewa Utainrat, Jessica Herkes-Deane, John Attia, Theo de Malmanche, Erdahl Teber, Kerrin Palazzi, Craig Scowen, Alexis Hure

21 April 2023

The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study

Mauro Scimia, Francesco Pepe, Gianluca Russo, Lucia Palumbo, Umberto Malapelle, Rachel Chuang, Simone Scimia, Michael Sha, Hiromi Tanaka, Shuo Shen, David Chen, Giancarlo Troncone, Maria Antonia Bianco

22 April 2024

Clinicopathological features of kidney injury in patients receiving immune checkpoint inhibitors (ICPi) combined with anti-vascular endothelial growth factor (anti-VEGF) therapy

Shi Jin, Ziyan Shen, Jie Li, Xueguang Liu, Qifan Zhu, Fang Li, Yiqin Shi, Pan Lin, Xialian Xu, Xiaohong Chen, Xuemei Geng, Xiaoqiang Ding, Hong Liu

19 January 2024

Landscape of cancer biomarker testing in England following genomic services reconfiguration: insights from a nationwide pathologist survey

Phillipe Taniere, Andrew G Nicholson, John R Gosney, Maria Angeles Montero Fernandez, Danielle Bury, David Allan Moore, Eldo Verghese, Irshad Soomro, Leena Joseph, Nidhi Bhatt, Patrizia Viola, Rozinder Bains, Adrienne G Lanctot, Jacqueline Ryan

31 May 2023

Prev 1 234 5 6 7 8 9 10 Next